Literature DB >> 33080508

A disentangled generative model for disease decomposition in chest X-rays via normal image synthesis.

Youbao Tang1, Yuxing Tang2, Yingying Zhu2, Jing Xiao3, Ronald M Summers2.   

Abstract

The interpretation of medical images is a complex cognition procedure requiring cautious observation, precise understanding/parsing of the normal body anatomies, and combining knowledge of physiology and pathology. Interpreting chest X-ray (CXR) images is challenging since the 2D CXR images show the superimposition on internal organs/tissues with low resolution and poor boundaries. Unlike previous CXR computer-aided diagnosis works that focused on disease diagnosis/classification, we firstly propose a deep disentangled generative model (DGM) simultaneously generating abnormal disease residue maps and "radiorealistic" normal CXR images from an input abnormal CXR image. The intuition of our method is based on the assumption that disease regions usually superimpose upon or replace the pixels of normal tissues in an abnormal CXR. Thus, disease regions can be disentangled or decomposed from the abnormal CXR by comparing it with a generated patient-specific normal CXR. DGM consists of three encoder-decoder architecture branches: one for radiorealistic normal CXR image synthesis using adversarial learning, one for disease separation by generating a residue map to delineate the underlying abnormal region, and the other one for facilitating the training process and enhancing the model's robustness on noisy data. A self-reconstruction loss is adopted in the first two branches to enforce the generated normal CXR image to preserve similar visual structures as the original CXR. We evaluated our model on a large-scale chest X-ray dataset. The results show that our model can generate disease residue/saliency maps (coherent with radiologist annotations) along with radiorealistic and patient specific normal CXR images. The disease residue/saliency map can be used by radiologists to improve the CXR reading efficiency in clinical practice. The synthesized normal CXR can be used for data augmentation and normal control of personalized longitudinal disease study. Furthermore, DGM quantitatively boosts the diagnosis performance on several important clinical applications, including normal/abnormal CXR classification, and lung opacity classification/detection.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Chest radiography (X-ray); Disease decomposition; Disentangled representation learning; Medical image synthesis

Mesh:

Year:  2020        PMID: 33080508     DOI: 10.1016/j.media.2020.101839

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  5 in total

1.  Generative models for reproducible coronary calcium scoring.

Authors:  Sanne G M van Velzen; Bob D de Vos; Julia M H Noothout; Helena M Verkooijen; Max A Viergever; Ivana Išgum
Journal:  J Med Imaging (Bellingham)       Date:  2022-05-31

2.  LDADN: a local discriminant auxiliary disentangled network for key-region-guided chest X-ray image synthesis augmented in pneumoconiosis detection.

Authors:  Li Fan; Zelin Wang; Jianguang Zhou
Journal:  Biomed Opt Express       Date:  2022-07-27       Impact factor: 3.562

3.  Anomaly detection in fundus images by self-adaptive decomposition via local and color based sparse coding.

Authors:  Yuchen Du; Lisheng Wang; Benzhi Chen; Chengyang An; Hao Liu; Ying Fan; Xiuying Wang; Xun Xu
Journal:  Biomed Opt Express       Date:  2022-07-21       Impact factor: 3.562

4.  Synthetic data in machine learning for medicine and healthcare.

Authors:  Richard J Chen; Ming Y Lu; Tiffany Y Chen; Drew F K Williamson; Faisal Mahmood
Journal:  Nat Biomed Eng       Date:  2021-06       Impact factor: 29.234

5.  Lung Disease Classification in CXR Images Using Hybrid Inception-ResNet-v2 Model and Edge Computing.

Authors:  Chandra Mani Sharma; Lakshay Goyal; Vijayaraghavan M Chariar; Navel Sharma
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.